Onyx Biotec Ltd

NSE: ONYX

₹38.60

up-down-arrow1.80 (4.89%)

As on 10-Jul-2026 15:31IST

Market cap

info icon

₹67 Cr

Revenue (TTM)

info icon

₹62 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

1.2

Div. Yield

info icon

0 %

Onyx Biotec Share Price

Compare

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 38.60 High: 38.60

52 Week Range

Low: 24.20 High: 53.90

Liquidityliquidity Low

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹5 Cr

  • ROEROE information

    12.2 %

  • ROCEROCE information

    13.7 %

  • Industry P/EIndustry P/E information

    40.36

  • EV/EBITDAEV/EBITDA information

    18.4

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    ₹30.7

  • EPSEPS information

    ₹2.7

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    18,132,200

Years Aggregate

CFO

₹--

EBITDA

₹--

Net Profit

₹--

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Onyx Biotec
-5.4 -8.1 18.8 -20.2 -- -- --
BSE Healthcare
15.0 5.8 17.8 12.3 24.4 14.1 12.0
As on 10-Jul-2026
Company
2025
Onyx Biotec
-55.9
BSE Small Cap
-6.6
BSE Healthcare
-3.3

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Onyx Biotec
38.6 66.7 62.0 5.0 -- 12.2 -- 1.2
1,160.6 2,149.1 77.0 16.4 -- 43.4 64.3 20.0
60.0 30.2 149.1 3.1 3.4 2.8 24.8 0.6
2,479.4 40,877.0 6,430.7 1,027.3 18.8 10.5 39.8 3.9
132.8 43.8 13.9 0.4 -- 5.6 99.6 5.4
219.8 1,209.2 277.9 26.4 9.9 8.3 41.7 5.0
826.1 9,922.7 6,892.5 219.6 4.7 11.5 45.2 5.0
33.0 58.0 167.8 5.9 -- 5.7 -- 0.6
119.9 64.2 61.7 6.3 -- 28.9 9 2.0
152.0 56.6 21.6 3.2 20.8 18.6 18 3.2

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

No Review & Analysis are available.

About Onyx Biotec

--

  • Incorporated

    2005

  • Chairman

    --

  • Managing Director

    Sanjay Jain

  • Headquarters

    Solan, Himachal Pradesh

  • Website

    www.onyxbiotec.com

Edit peer-selector-edit
loading...
loading...

Announcements

View Announcements

No News & Announcements are available.

FAQs for Onyx Biotec

The share price of Onyx Biotec Ltd is ₹38.60 (NSE) as of 10-Jul-2026 15:31 IST. Onyx Biotec Ltd has given a return of -20.17% in the last 1 years.

Since, TTM earnings of Onyx Biotec Ltd is negative, P/E ratio is not available.
The P/B ratio of Onyx Biotec Ltd is 1.20 times as on 09-Jul-2026, a 50 discount to its peers’ median range of 2.38 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
21.23
1.89
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00
2025
21.23
1.89

The 52-week high and low of Onyx Biotec Ltd are Rs 53.90 and Rs 24.20 as of 10-Jul-2026.

Onyx Biotec Ltd has a market capitalisation of ₹ 67 Cr as on 09-Jul-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Onyx Biotec Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.